GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Warrant Pharmaceutical Co Ltd (SHSE:688799) » Definitions » Change In Receivables

Hunan Warrant Pharmaceutical Co (SHSE:688799) Change In Receivables : ¥0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Hunan Warrant Pharmaceutical Co Change In Receivables?

Hunan Warrant Pharmaceutical Co's change in receivables for the quarter that ended in Mar. 2025 was ¥0 Mil. It means Hunan Warrant Pharmaceutical Co's Accounts Receivable stayed the same from Dec. 2024 to Mar. 2025 .

Hunan Warrant Pharmaceutical Co's change in receivables for the fiscal year that ended in Dec. 2024 was ¥-119 Mil. It means Hunan Warrant Pharmaceutical Co's Accounts Receivable increased by ¥119 Mil from Dec. 2023 to Dec. 2024 .

Hunan Warrant Pharmaceutical Co's Accounts Receivable for the quarter that ended in Mar. 2025 was ¥167 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Hunan Warrant Pharmaceutical Co's Days Sales Outstanding for the three months ended in Mar. 2025 was 45.25.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Hunan Warrant Pharmaceutical Co's liquidation value for the three months ended in Mar. 2025 was ¥42 Mil.


Hunan Warrant Pharmaceutical Co Change In Receivables Historical Data

The historical data trend for Hunan Warrant Pharmaceutical Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Warrant Pharmaceutical Co Change In Receivables Chart

Hunan Warrant Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -24.17 -31.56 11.32 -51.33 -118.65

Hunan Warrant Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Hunan Warrant Pharmaceutical Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hunan Warrant Pharmaceutical Co  (SHSE:688799) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Hunan Warrant Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=166.728/336.233*91
=45.25

2. In Ben Graham's calculation of liquidation value, Hunan Warrant Pharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

Hunan Warrant Pharmaceutical Co's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=304.513-596.112+0.75 * 166.728+0.5 * 416.299
=42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hunan Warrant Pharmaceutical Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Hunan Warrant Pharmaceutical Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Hunan Warrant Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 28 Lutian Road, Building C6-C7, Yuelu District, Changsha, CHN, 410006
Hunan Warrant Pharmaceutical Co Ltd is a pharmaceutical manufacturer. It is engaged in the research and development, production and sales of chemical raw materials, chemical medicine preparations and Chinese medicine preparations.
Executives
Jin Yan Supervisors

Hunan Warrant Pharmaceutical Co Headlines

No Headlines